Skip to content

Measuring the impairment of different doses of alcohol on skills related to car driving

Measuring the impairment of different doses of alcohol on skills related to car driving - Dose-effects of alcohol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37549
Enrollment
24
Registered
2012-02-29
Start date
2012-03-12
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

n.v.t. Het betreft gezonde vrijwilligers die alleen alcohol toegediend krijgen n.v.t.

Interventions

Treatments are three doses of alcohol sufficient to raise blood alcohol concentrations to 0.2, 0.5, and 0.8 mg/ml BAC, and placebo (BAC 0.0 mg/ml).

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy Age 18 till 30 (inclusive) BMI between 19 and 29

Exclusion criteria

Exclusion criteria: Smoking more than 7 cigarettes per week Drinking more than 6 cups of caffein and/or xanthine containing products per day Drinking less than 3 or more than 21 glasses of alcohol per week Use of drugs For women: pregnancy

Design outcomes

Primary

MeasureTime frame
The primary dependent variable is tracking error in the divided attention test (DAT).

Secondary

MeasureTime frame
Average reaction time of the divided attention task (DAT), Tracking accuracy at the critical tracking test (CTT), number of digits processed at the Digit Symbol Substitution Test, mean reaction time at the Psychomotor Vigilance Test (PVT), reaction time and accuracy at the Concept Shifting Test (CST), number of recalled sequences at the Digit Span Test, mean reaction time and accuracy at the Attention Network Test (ANT), and the AP95 (area of the 95% confidence ellipse enclosing the center of pressure) at a balance test.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)